Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

861 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.
Fond G, Faugere M, Boyer L, Peri P, Stephan F, Moliere F, Anguill L, Bennabi D, Haffen E, Bouvard A, Walter M, Samalin L, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, Rey R, Horn M, Vaiva G, Hennion V, Etain B, El-Hage W, Camus V, Courtet P, Aouizerate B, Yrondi A, Lancon C, Richieri R. Fond G, et al. Among authors: leboyer m. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Aug 30;126:110779. doi: 10.1016/j.pnpbp.2023.110779. Epub 2023 Apr 27. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 37120004
Physical and mental health status of former smokers and non-smokers patients with bipolar disorder.
Nobile B, Godin O, Gard S, Samalin L, Brousse G, Loftus J, Aubin V, Belzeaux R, Dubertret C, Le Strat Y, Mazer N, de Prémorel A, Roux P, Polosan M, Schwintzer T, Llorca PM; FondaMental Advanced Center of Expertise for Bipolar Disorders (FACE-BD) collaborators; Biseul I, Etain B, Moirand R, Olié E, Haffen E, Leboyer M, Courtet P, Guillaume S, Icick R. Nobile B, et al. Among authors: leboyer m. Acta Psychiatr Scand. 2023 Apr;147(4):373-388. doi: 10.1111/acps.13535. Epub 2023 Mar 1. Acta Psychiatr Scand. 2023. PMID: 36751870
Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markers.
Maruani J, Molière F, Godin O, Yrondi A, Bennabi D, Richieri R, El-Hage W, Allauze E, Anguill L, Bouvard A, Camus V, Dorey JM, Etain B, Fond G, Genty JB, Haffen E, Holtzmann J, Horn M, Kazour F, Nguon AS, Petrucci J, Rey R, Stephan F, Vaiva G, Walter M; FondaMental Advanced Centers of Expertise in Resistant Depression (FACE-DR) Collaborators; Lejoyeux M, Leboyer M, Llorca PM, Courtet P, Aouizerate B, Geoffroy PA. Maruani J, et al. Among authors: leboyer m. J Affect Disord. 2023 May 15;329:369-378. doi: 10.1016/j.jad.2023.02.106. Epub 2023 Feb 24. J Affect Disord. 2023. PMID: 36842655
Definition of early age at onset in bipolar disorder according to distinctive neurodevelopmental pathways: insights from the FACE-BD study.
Corponi F, Lefrere A, Leboyer M, Bellivier F, Godin O, Loftus J, Courtet P, Dubertret C, Haffen E, Llorca PM, Roux P, Polosan M, Schwan R, Samalin L, Olié E, Etain B; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorder) Groups; Seriès P, Belzeaux R. Corponi F, et al. Among authors: leboyer m. Psychol Med. 2023 Oct;53(14):6724-6732. doi: 10.1017/S003329172300020X. Epub 2023 Feb 28. Psychol Med. 2023. PMID: 36852971
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. Among authors: leboyer m. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise - Bipolar Disorder cohort.
Flaudias V, Samalin L, Godin O, Gard S, Brousse G, Loftus J, Aubin V, Belzeaux R, Dubertret C, Le Strat Y, Mazer N, de Prémorel A, Roux P, Polosan M, Schwitzer T, Aouizerate B, Llorca PM; FondaMental Advanced Centers of Expertise for Bipolar Disorder (FACE-BD) collaborators; Biseul I, Etain B, Moirand R, Olié E, Haffen E, Leboyer M, Courtet P, Icick R, Guillaume S. Flaudias V, et al. Among authors: leboyer m. J Affect Disord. 2023 Aug 15;335:177-185. doi: 10.1016/j.jad.2023.05.017. Epub 2023 May 12. J Affect Disord. 2023. PMID: 37178826
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, Courtet P, D'Amato T, Dubertret C, Etain B, Haffen E, Januel D, Leboyer M, Lefrere A, Llorca PM, Marlinge E, Olié E, Polosan M, Schwan R, Walter M; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group; Passerieux C, Roux P. Vidal N, et al. Among authors: leboyer m. Eur Neuropsychopharmacol. 2023 Dec;77:67-79. doi: 10.1016/j.euroneuro.2023.08.502. Epub 2023 Sep 21. Eur Neuropsychopharmacol. 2023. PMID: 37741163
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F, Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Fond G, et al. Among authors: leboyer m. BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. BMJ Ment Health. 2023. PMID: 37852631 Free PMC article.
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
Salles J, Stephan F, Molière F, Bennabi D, Haffen E, Bouvard A, Walter M, Allauze E, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, D'Amato T, Rey R, Horn M, Vaiva G, Fond G, Richieri R, Hennion V, Etain B, El-Hage W, Camus V; FondaMental Advanced Centers of Expertise in Resistant Depression (FACE-DR) collaborators; Courtet P, Aouizerate B, Yrondi A. Salles J, et al. Among authors: leboyer m. J Affect Disord. 2024 Feb 15;347:306-313. doi: 10.1016/j.jad.2023.11.063. Epub 2023 Nov 20. J Affect Disord. 2024. PMID: 37992775
861 results